Heron Therapeutics, Inc. (HRTX): Price and Financial Metrics

HRTX POWR Grades

• Value is the dimension where HRTX ranks best; there it ranks ahead of 73.5% of US stocks.
• HRTX's strongest trending metric is Growth; it's been moving down over the last 177 days.
• HRTX's current lowest rank is in the Stability metric (where it is better than 9.26% of US stocks).

HRTX Stock Summary

• The capital turnover (annual revenue relative to shareholder's equity) for HRTX is -3 -- better than only 3.76% of US stocks.
• HRTX's went public 36.11 years ago, making it older than 91.99% of listed US stocks we're tracking.
• Equity multiplier, or assets relative to shareholders' equity, comes in at -64.33 for HERON THERAPEUTICS INC; that's greater than it is for only 0.36% of US stocks.
• If you're looking for stocks that are quantitatively similar to HERON THERAPEUTICS INC, a group of peers worth examining would be RAMP, RPD, ASAN, BLZE, and BFLY.
• Visit HRTX's SEC page to see the company's official filings. To visit the company's web site, go to www.herontx.com.

HRTX Valuation Summary

• In comparison to the median Healthcare stock, HRTX's price/sales ratio is 70% lower, now standing at 1.2.
• HRTX's price/sales ratio has moved down 6.7 over the prior 243 months.

Below are key valuation metrics over time for HRTX.

HRTX Growth Metrics

The 4 year revenue growth rate now stands at 2745.98%.
• The 2 year net cashflow from operations growth rate now stands at -89.28%.
• The 5 year net cashflow from operations growth rate now stands at 28.78%.

HRTX's revenue has moved up $15,268,000 over the prior 15 months.

The table below shows HRTX's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2022-09-30	98.299	-154.636	-216.801
2022-06-30	94.972	-170.736	-227.301
2022-03-31	89.785	-205.355	-231.957
2021-12-31	86.346	-203.354	-220.683
2021-09-30	86.296	-210.65	-228.318
2021-06-30	83.031	-199.538	-234.138

HRTX's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• HRTX has a Quality Grade of D, ranking ahead of 9.05% of graded US stocks.
• HRTX's asset turnover comes in at 0.243 -- ranking 181st of 682 Pharmaceutical Products stocks.
• IBIO, COLL, and PTGX are the stocks whose asset turnover ratios are most correlated with HRTX.

The table below shows HRTX's key quality metrics over time.